Ji-Min Health: repurchased 1,705,500 shares with a total funding of 10.33 million yuan.

Ji Min Health announced on April 30th that the company held the 17th meeting of the fifth board of directors on March 28, 2025, and approved the proposal on the repurchase of shares through centralized competitive trading. The company agreed to use its own funds and borrowings from financial institutions to repurchase company shares through centralized competitive trading at a price not exceeding RMB 10 per share; the total amount of repurchase funds shall not be less than RMB 100 million and not more than RMB 200 million; the repurchase period shall not exceed 12 months from the date of approval by the board of directors. As of April 30, 2025, the company has repurchased a total of 1.7055 million shares, accounting for 0.32% of the total share capital of the company, with a repurchase price range of RMB 5.91 per share to RMB 6.13 per share, and a total fund used of RMB 10.33 million.